Escherichia infection – Diagnostics – Overview of Information and Clinical Research

Diagnosing Escherichia coli infection requires identifying the specific bacteria causing your symptoms through laboratory testing, which helps doctors determine the right approach to care and avoid serious complications like kidney failure.

Introduction: Who Should Undergo Diagnostics and When

If you develop symptoms like watery diarrhea, stomach cramps, nausea, or vomiting, especially if the diarrhea becomes bloody, you should contact your doctor promptly to determine whether testing for E. coli infection is needed. E. coli is a type of bacteria that normally lives harmlessly in the intestines of people and animals, but certain strains can cause illness ranging from mild digestive upset to severe, life-threatening complications^[1].

People who are at higher risk for severe illness should seek medical attention earlier rather than later. This includes children younger than five years old, adults aged 65 and older, people with weakened immune systems, and international travelers^[1]. These groups are more vulnerable to developing serious complications from E. coli infection, so early diagnosis becomes especially important for them.

You should seek diagnostic testing if your symptoms are persistent, severe, or bloody. Contact your doctor if you have diarrhea that lasts more than a few days, if you see blood in your stool, if you develop a high fever, or if you experience severe abdominal pain^[5]. These symptoms may indicate a more dangerous strain of E. coli that produces toxins capable of damaging your kidneys and blood cells.

Signs of dehydration—which means your body doesn’t have enough water—should also prompt you to seek medical care. Dehydration symptoms include extreme tiredness, dry mouth or tongue, feeling very thirsty, dizziness when standing up, confusion, dark yellow urine, or not urinating for more than five hours^[13]. Diarrhea causes your body to lose fluids rapidly, and young children and older adults are particularly vulnerable to becoming dehydrated.

If you develop symptoms of a urinary tract infection, such as pain or burning when urinating, needing to urinate frequently and urgently, cloudy or foul-smelling urine, or pelvic pain, diagnostic testing can determine whether E. coli has infected your urinary system^[2]. E. coli that normally lives in your gut can sometimes get into places it shouldn’t be, like your urinary tract, causing infections there.

⚠️ Important

Symptoms of E. coli infection typically begin three to four days after exposure to the bacteria, though they can start as soon as one day or as late as ten days after contact^[5]. Most people recover within about a week, but some develop serious complications that require immediate medical attention. If you suspect E. coli infection, especially if you or your child fall into a high-risk group, contact your doctor right away.

Diagnostic Methods Used to Identify E. coli Infection

The primary method doctors use to diagnose E. coli infection is testing a sample of your stool in a laboratory. When you visit your doctor with symptoms suggesting E. coli infection, they will ask you to provide a stool sample, which is then sent to a lab where technicians look for the presence of E. coli bacteria^[9]. This straightforward test is the foundation of E. coli diagnosis.

In the laboratory, technicians perform what’s called a culture of the bacteria. This means they try to grow the bacteria from your stool sample under controlled conditions to confirm the diagnosis and identify the specific type of E. coli causing your illness^[9]. Different strains of E. coli behave differently and require different management approaches, so identifying the exact strain helps guide your care.

One particularly important aspect of laboratory testing is identifying whether the E. coli produces something called Shiga toxin. Shiga toxin-producing E. coli, often abbreviated as STEC, is the type most likely to cause severe illness and serious complications^[2]. The most well-known strain is E. coli O157:H7, which has been responsible for many outbreaks and severe cases. However, other strains can also produce Shiga toxin and cause similar problems.

Modern clinical laboratories should routinely test stool samples in two ways: they should culture for E. coli O157, and they should simultaneously test for non-O157 STEC using a method that detects either the Shiga toxins themselves or the genes that tell the bacteria how to make these toxins^[16]. This comprehensive approach ensures that dangerous strains aren’t missed, even if they’re not the most common type.

When a laboratory finds E. coli O157 or detects evidence of Shiga toxin in your sample, the specimen should be sent to a public health laboratory for additional characterization^[16]. This step helps health authorities track outbreaks and understand patterns of infection in the community. Public health laboratories have specialized equipment and expertise to perform detailed analysis of the bacteria.

For urinary tract infections caused by E. coli, doctors typically order a urine test rather than a stool test. The urine sample is examined in a laboratory to look for bacteria and signs of infection^[17]. This type of testing helps determine whether E. coli or another bacteria is causing your urinary symptoms.

It’s worth noting that most clinical laboratories in many countries do not routinely test for types of diarrheagenic E. coli—meaning types that cause diarrhea—other than STEC^[16]. There are several other categories of E. coli that can cause intestinal illness, including enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), and diffusely adherent E. coli (DAEC). Public health laboratories typically only test for these during an outbreak of diarrheal illness when the cause is unknown.

The timing of accurate diagnosis matters considerably. Rapid and accurate identification of STEC infection is particularly important because early clinical decisions can affect patient outcomes, and early detection helps prevent the bacteria from spreading to other people^[16]. When doctors know quickly what they’re dealing with, they can provide better guidance and monitoring.

Standard blood tests may also be ordered to check for complications, especially if your doctor suspects that the infection has progressed to hemolytic uremic syndrome (HUS). HUS is a serious condition characterized by the destruction of red blood cells, kidney injury, and low platelet counts^[16]. Blood chemistry tests and blood counts can reveal these problems and help doctors determine whether more intensive treatment is needed.

Diagnostics for Clinical Trial Qualification

The sources provided do not contain specific information about diagnostic tests or methods used as standard criteria for enrolling patients in clinical trials for E. coli infection. Clinical trial qualification criteria for E. coli infections are not detailed in the available materials.

Prognosis and Survival Rate

Prognosis

Most people who develop E. coli infection recover completely within about one week without experiencing any further problems^[15]^[21]. For the majority of patients, the illness remains mild and self-limiting, meaning it goes away on its own without requiring medical intervention beyond rest and fluids. Healthy adults typically recover from E. coli infection within five to ten days without needing antibiotics or other medications^[20].

However, some people develop severe blood and kidney problems that can dramatically alter their prognosis^[15]^[21]. The most serious complication is hemolytic uremic syndrome (HUS), a life-threatening condition that can lead to permanent kidney damage or even death. Studies suggest that up to 10 percent of patients with STEC infection may develop HUS^[3]. This complication is particularly likely to occur in young children under five years old and older adults.

Several factors influence whether a person will experience a good or poor outcome. Young children and the elderly face greater risks of developing life-threatening kidney failure from E. coli O157:H7 infection^[5]. People with weakened immune systems are also at increased risk for severe illness^[1]. Additionally, taking antacids can increase the risk of infection and potentially more severe outcomes because stomach acid normally helps kill bacteria that are swallowed^[14].

For those who develop HUS, the prognosis depends partly on how quickly treatment begins and the quality of supportive care received. People who develop HUS are usually treated in an intensive care unit with blood transfusions and kidney dialysis^[16]. With good supportive care, most people with HUS recover completely, and outcomes are typically better for children than for adults^[16]. However, some patients may experience permanent health problems, including chronic kidney disease.

Evidence from studies of children with STEC O157 infection indicates that early use of intravenous fluids—within the first four days of diarrhea onset—may decrease the risk of developing kidney failure^[16]. This finding emphasizes the importance of seeking medical care promptly when symptoms appear, particularly for those in high-risk groups.

Survival rate

The death rate for hemolytic uremic syndrome (HUS), the most serious complication of E. coli infection, is approximately 3 to 5 percent in the United States^[20]. This means that among people who develop HUS, about 3 to 5 out of every 100 will die from this complication. While this percentage may seem relatively small, it represents a significant number of deaths given that there are about 265,000 Shiga toxin-producing E. coli (STEC) infections each year in the United States alone^[2].

For people who do not develop HUS, the survival rate is much higher. Most patients with E. coli infection who receive appropriate supportive care recover fully without life-threatening complications. The key to improving survival rates is early recognition of symptoms, prompt medical attention for those at high risk, appropriate hydration to prevent kidney damage, and avoiding treatments that might increase the risk of HUS, such as antibiotics and anti-diarrheal medications when STEC infection is suspected.

#1 Clinical Trials Search in Europe